Constantinos Panousis

Constantinos Panousis, PhD

Constantinos G. Panousis received a Chemistry degree from the University of Athens Greece, and his PhD from the University of Pittsburgh. Dr Panousis completed his post-doctoral training as a Molecular Pharmacologist in Indianapolis with the Eli Lilly and Company. 

In 2000, he joined Hoffman La-Roche in Basel, Switzerland, where he served as a Senior Principal Scientist in the department of Metabolic Diseases and he led several preclinical programs, having one moving to Phase I clinical trials. In 2008, he returned to the US to continue his drug discovery efforts for diabetes and acute kidney injury indications with Hoffman La Roche in Nutley, NJ.

In 2011, he returned to Pittsburgh where he held consulting and research positions at the University of Pittsburgh until he joined Dr Shlomchik’s lab in 2017.

Dr Panousis, BlueSphere Bio’s Vice President of Research and Development and one of its founders, played an instrumental role in the development of the TCXpress™ technology.